Congress trades
Onconetix, Inc. (ONCO)
Free on iOS and Android.
About Onconetix, Inc.
from the company's filings and listing, as of Oct 25, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- David Allan White
- Employees
- 2
- Listed since
- Feb 18, 2022
- Market value
- $1.5M
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$4.55
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 12, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 13, 2026 | -$1.28 | n/a | $17K | $17K | EPS n/aRevenue in line |
| Q1 FY2026reported May 13, 2026 | -$6.71 | n/a | $21K | n/a | EPS n/aRevenue n/a |
| Q4 FY2025reported Mar 12, 2026 | $12.58 | n/a | $304K | n/a | EPS n/aRevenue n/a |
| Q3 FY2025reported Nov 13, 2025 | -$31.25 | n/a | $304K | n/a | EPS n/aRevenue n/a |
| Q2 FY2025reported Aug 14, 2025 | -$2.03 | n/a | $106K | n/a | EPS n/aRevenue n/a |
| Q1 FY2025reported Jun 12, 2025 | $10.59 | n/a | $102K | n/a | EPS n/aRevenue n/a |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A figure or flag reads n/a when a number is missing, or when the figure failed our check against the company's other quarters, its own filings and its share splits, and was left out. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in ONCO
19 disclosures of 19 on record · median 24d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -99.7%After the saleS&P 500 +14.4% · -114.1 pts vs S&P 500 | Oct 17, 2025 | Nov 10, 2025 | 24d |
| Michael T. McCaul | Stock | Purchase | $1,001 - $15,000 | n/a | Oct 11, 2023 | Nov 13, 2023 | 33d |
| Michael T. McCaul | Stock | Sale | $100,001 - $250,000 | n/a | Aug 24, 2023 | Sep 14, 2023 | 21d |
| Michael T. McCaul | Stock | Purchase | $100,001 - $250,000 | n/a | Jul 14, 2023 | Aug 16, 2023 | 33d |
| Michael T. McCaul | Stock | Purchase | $100,001 - $250,000 | n/a | Apr 18, 2023 | May 12, 2023 | 24d |
| Charles J. "Chuck" Fleischmann | Stock | Purchase | $1,001 - $15,000 | n/a | Apr 10, 2023 | May 9, 2023 | 29d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/a | Mar 14, 2023 | Apr 7, 2023 | 24d |
| Michael T. McCaul | Stock | Purchase | $100,001 - $250,000 | n/a | Jan 3, 2023 | Feb 15, 2023 | 43d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/a | Sep 29, 2022 | Oct 7, 2022 | 8d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | n/a | Jun 27, 2022 | Jul 7, 2022 | 10d |
| Ro KhannaNot shares: HONOLULU HAWAII CITY & CNTY REV 5. | Bond | Sale | $15,001 - $50,000 | n/a | Jun 30, 2022 | Jul 7, 2022 | 7d |
| Diana Harshbarger | Stock | Purchase | $1,001 - $15,000 | n/a | May 16, 2022 | May 26, 2022 | 10d |
| Michael T. McCaul | Stock | Purchase | $100,001 - $250,000 | n/a | Jan 26, 2022 | Feb 23, 2022 | 28d |
| Michael T. McCaulNot shares: HONOLULU HAWAII CITY& CNTY GO BDS | Bond | Purchase | $1,001 - $15,000 | n/a | Jan 22, 2019 | Feb 25, 2019 | 34d |
| Michael T. McCaul | Stock | Sale | $15,001 - $50,000 | n/a | Oct 24, 2018 | Nov 15, 2018 | 22d |
| Michael T. McCaulNot shares: HONOLULU HAWAII CITY& CNTY G O BDS | Bond | Purchase | $100,001 - $250,000 | n/a | Aug 28, 2018 | Sep 12, 2018 | 15d |
| Michael T. McCaulNot shares: HONOLULU HAWAII CITY& CNTY GO BDS | Bond | Purchase | $100,001 - $250,000 | n/a | Sep 6, 2018 | Sep 12, 2018 | 6d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | n/a | Dec 9, 2015 | Feb 3, 2016 | 56d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | n/a | Mar 6, 2014 | Apr 10, 2014 | 35d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in ONCO, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded ONCO?
Michael T. McCaul, Charles J. "Chuck" Fleischmann, Ro Khanna and Diana Harshbarger disclosed ONCO transactions in the filings shown here.
How quickly are ONCO trades disclosed?
Congressional disclosures took a median of 24 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.